Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Urologic Neoplasms × Etoposide × Clear all

Sponsor

Conditions

Lymphoma 61 Lymphoma, Non-Hodgkin 44 Lymphoma, Large B-Cell, Diffuse 41 Precursor Cell Lymphoblastic Leukemia-Lymphoma 38 Hodgkin Disease 38 Leukemia, Myeloid, Acute 36 Leukemia 34 Small Cell Lung Carcinoma 33 Burkitt Lymphoma 26 Lymphoma, Follicular 25 Lymphoma, Mantle-Cell 24 Lung Neoplasms 18 Carcinoma, Non-Small-Cell Lung 17 Multiple Myeloma 15 Lymphoma, Large-Cell, Immunoblastic 15 Lymphoma, Large-Cell, Anaplastic 14 Leukemia, Lymphocytic, Chronic, B-Cell 14 Congenital Abnormalities 14 Recurrence 13 Lymphoma, B-Cell, Marginal Zone 13 Neuroblastoma 12 Neoplasms 12 Lymphoma, B-Cell 12 Myelodysplastic Syndromes 11 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 10 Immunoblastic Lymphadenopathy 10 Sarcoma 9 Myeloproliferative Disorders 9 Lymphoma, T-Cell 9 Waldenstrom Macroglobulinemia 8

Interventions

Trastuzumab 2 valrubicin 1 niraparib 1 enfortumab vedotin 1 avelumab 1 Surveys and Questionnaires 1 Sunitinib 1 Sugammadex 1 Standard of Care 1 Paclitaxel 1 Neostigmine 1 Neoadjuvant Therapy 1 Gemcitabine 1 Docetaxel 1 Cisplatin 1 Cetuximab 1 Afatinib 1 Administration, Intravesical 1 1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡